Find A Physician
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
Hospital News
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education
- NewYork-Presbyterian Hospital Goes Smoke-Free on August 10th
- Teaching Your Belly to Feel Full
- Unique Cardiac Training Gives NewYork-Presbyterian/Columbia Doctor Ability to Treat Heart Patients With Hybrid Approach
- Dr. Holly Andersen to Lead Education and Outreach at New Ronald O. Perelman Heart Institute of NewYork-Presbyterian/Weill Cornell
- Presence of Gum Disease May Help Dentists and Physicians Identify Those at Increased Risk for Cardiovascular Disease
- Gender Differences and Heart Disease
- First Gene Therapy for Heart Failure Offered at NewYork-Presbyterian Hospital/Columbia University Medical Center
- JAMA Article Looks at Data-Sharing in Clinical Trials for Heart Disease
- Dr. Antonio M. Gotto and Dr. Herbert Pardes Awarded Austrian Cross of Honor for Science and Art
- Surgeons Who Helped Pioneer Revolutionary Technique Present International Course on NOTES Surgery
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- For High Blood Pressure Patients, Preventing or Reducing Enlarged Heart May Decrease Risk for Diabetes
- Columbia Scientists Study Advantages of Using Web to Tailor Medical Information to Patients
- For High-Blood-Pressure Patients, Preventing or Reducing Enlarged Heart Decreases Risk of Heart Failure
- Hot Flashes in Women Linked to High Blood Pressure, According to New Weill Cornell Study
- Oh, My Aching Back! Tips on Avoiding Back Injury From NewYork-Presbyterian's Spine Center
- Scientific Evidence Points to Male Biological Clock
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- NewYork-Presbyterian Receives Highest Accreditation for Bariatric Surgery
- How to Avoid Holiday and Winter Weight Gain
- Merry Stressmas
- From Ancient Egypt to the Science Lab to Your Dinner Plate... Garlic: It's Good for You!
- Diabetics Benefit Less from Anti-Hypertensive Treatment to Reduce Enlarged Heart
- Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
- Electrocardiogram Helps Predict Risk for Congestive Heart Failure in Hypertensive Patients
- Heart Health Inspiration & Strategies for the Whole Family
- The Ties That Bind Us Can Also Heal Us
- Columbia Research Suggests Need to Rethink Causes of Heart Failure
- New Treatment for Enlarged Heart Effective, NewYork Weill Cornell Study Shows
- Reducing Enlarged Heart Muscle Cuts Patients' Cardiac Risk, Independent of Lowered Blood Pressure, NewYork-Presbyterian/Weill Cornell Researchers Report
- Omega-3 Fatty Acids: Good For the Heart, and (Maybe) Good for the Brain
- NewYork Weill Cornell Research Highlights Need To Focus on Frequently Neglected Neurogenic Hypertension
- New Laser Technology Offers Promise for Heart Disease Patients
- Research Shows Cholesterol-Lowering Drug Lovastatin Reduces Risk of Heart Attack in Healthy Adults
- Job Strain Linked to High Blood Pressure, Heart Disease Risk
- Lovastatin Treatment Reduces Events in Patients at Varying Degrees of Coronary Risk and Reduces Need for Invasive Procedures
- The Mind/Body Link in Essential Hypertension: Time for a New Paradigm
- "Bad" Cholesterol May Not Be the Best Predictor of Heart Disease Risk in Generally Healthy Individuals
- Weill Cornell Dean and Cardiovascular Expert Makes "Top Ten" Texas List
- Is Garlic Good for Your Heart? A Review of the Evidence
- Genetic Medicine Program at Weill Cornell Receives Major Boost from The Starr Foundation
- Weill Cornell Researchers Identify a Likely Genetic Cause of Atherosclerosis
- Weill Cornell Researcher Shows How Progesterone Is Not Just Sex Hormone but Blood Pressure Hormone
- Dean Antonio M. Gotto, Jr., Elected Fellow of American Academy of Arts and Sciences
- Losartan Better Than Beta-Blocker at Shrinking Enlarged Hearts, NewYork-Presbyterian/Weill Cornell Study Shows
- Low-Dose, Over-the-Counter Statins May Be Safe, Effective Aid in Preventing Heart Disease for Americans at Moderate Risk, Says Weill Cornell Dean
- Weill Cornell Physician-Scientists Win 2 Top Awards at American Heart Association Meeting
- 9/11 Lifestyle Changes May Increase Cardiovascular Risk
- Weill Cornell Receives $7.6 Million Federal Grant for Clinical Trials on New Ways To Change Behavior in Patients With Cardiopulmonary Disease
- Comprehensive Review Finds Job Stress Does Not Contribute to Chronic High Blood Pressure
- Researcher Predicts Paradigm Shift in Heart Disease Treatment
- NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
Research and Clinical Trials
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
Health Library
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- Cardiovascular Disease Prevention
- Cardiovascular Disease Prevention: Lifestyle Changes
- Cholesterol in the Blood
- Diabetes and Heart Disease
- Diabetes and High Blood Pressure
- High Blood Pressure (Hypertension)
- Lifestyle Changes
- Maintaining Weight Loss
- Metabolic Syndrome
- Obesity
- Obesity: Medical Treatment
- Obesity Overview
- Obesity Prevention
- Obesity Treatment Overview
- Smoking and Cardiovascular Disease
Clinical Services
More on Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Artificial Heart Devices: LVAD
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Coronary Artery Bypass Surgery (Grafting)
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Transplant Surgery
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-pump Surgery
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Public Health
- Robotic Heart Surgery
- Surgery for Adult Congenital Heart Disease
- The Corporate Care System
- Transmyocardial Revascularization
- Treatment of Peripheral Arterial Disease
Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
NEW YORK (Apr 27, 2006)
Cardiovascular disease (CVD), or disease of the heart and blood vessels, continues to be a leading killer of men and women in the United States, accounting for close to 30 percent of all deaths annually. According to a leading researcher, CVD will remain a major cause of death unless Americans make a concerted effort to manage all of their risks.
"It's going to take a lot more than one small lifestyle change to reduce the toll of cardiovascular disease significantly," said Antonio M. Gotto Jr., MD, DPhil, dean and professor of medicine at the Weill Medical College of Cornell University in New York. "Although patients can't control their age, race and genetics, they can make positive changes that will affect their blood pressure, cholesterol levels, risk for diabetes, and weight, all of which contribute to cardiovascular disease."
Dr. Gotto spoke today at an American Medical Association media briefing, Cardiovascular Disease, in New York City.
Redefining Risk
The risks patients must consider and manage today differ substantially from the risks their parents and grandparents had to consider, said Dr. Gotto. At one time, cigarette smoking was a common practice and people were not as conscious of diet and exercise.
"Over the last 20 years, even the defining levels of cardiovascular risk factors have changed," explained Dr. Gotto. "We used to believe that an LDL, or bad cholesterol, level over 160 was too high, then it changed to 130 and then 100, as more clinical evidence became available. Now, based on the data, patients at very high risk for disease may need to keep their LDL under 70."
The same is true for high blood pressure. An "optimal" level was once considered less than 120/80 mm Hg. Now that same goal is considered "normal." A systolic blood pressure in the range of 120-140 mm Hg is now considered "pre-hypertension," a warning of blood pressure issues to come.
And the worldwide challenge of cardiovascular diseases is only likely to grow in the future. "As changes occur in the developing world, we're faced with an entirely new set of issues to combat in relation to cardiovascular disease, such as obesity and diabetes," Dr. Gotto added.
Management of all Risks
"The more risk factors someone has, the more likely he or she is to have cardiovascular disease," explained Dr. Gotto. "Having multiple risk factors exponentially increases your risk for having a heart attack or stroke. In cases where patients have two or more risk factors, the heart disease risk caused by the whole package is much worse than the risk associated with each individual risk factor."
In essence, this theory can also apply to prevention and management of risk factors; the more risk factors managed, the greater chance a patient can prevent heart disease.
"Research into risk has been extremely beneficial in giving physicians a better understanding of how they can help their patients," said Dr. Gotto. "The Diabetes Prevention Program demonstrated that several lifestyle changes, such as diet and exercise, can help prevent diabetes. But other studies, such as the Women's Health Initiative, suggest that making only one change, in this case a low-fat diet, isn't enough."
"Diet and exercise will only be effective if people also lower their blood pressure and cholesterol," he said. "Without management of all the issues related to one's cardiovascular health, it is very unlikely patients will reduce risk substantially and prevent disease."
Editor's Note: Dr. Gotto serves as a consultant for AstraZeneca Pharmaceuticals, Bristol Myers Squibb, Johnson & Johnson Merck, KOS Pharmaceuticals, KOWA, Merck, Merck/Schering-Plough, Novartis, Pfizer, and Reliant. He sits on the Board of Directors for Medtronic. Dr. Gotto has received an honorarium from the American Medical Association to speak at today's conference.Contact
- Kathleen Robinson
- krobinso@med.cornell.edu
